Zimmer Biomet Holdings (LTS:0QQD) Valuation Rank


LTS:0QQD Zimmer Biomet Holdings Inc LTS:0QQD
72 GF Score
Price CHF77.38
GF Value CHF106.97
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Zimmer Biomet Holdings Valuation Rank Related Terms

LTS:0QQD
72GF Score
Zimmer Biomet Holdings Inc LTS:0QQD
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zimmer Biomet Holdings (LTS:0QQD) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF77.38 is trading 27.7% below its estimated GF Value™ of CHF106.97.

Key valuation signals for LTS:0QQD:

  • Valuation Rank:
  • GF Value™: CHF106.97 vs. price of CHF77.38 (27.7% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the LTS:0QQD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
72GF Score

Get the complete analysis for LTS:0QQD

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF77.38
Price
CHF106.97
GF Value